Biotechnology Europe Approves Bristol Myers Squibb’s CAR-T Therapy For Early Treatment Of Type Of Blood Cancer – Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology PRISM MarketView Spotlights Companies Leading the Charge in Liver Disease Treatment Following Landmark FDA Approval Read more
Biotechnology Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura in Canada – Scilex Holding (NASDAQ:SCLX) Read more
Biotechnology Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome – Entera Bio (NASDAQ:ENTX) Read more
Biotechnology Gilead’s Aggressive Push Beyond HIV Treatments – Plans To Increase Cancer-Focused CAR-T Treatment Production – Gilead Sciences (NASDAQ:GILD) Read more
Biotechnology Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data – Immuneering (NASDAQ:IMRX) Read more
Biotechnology Spruce Biosciences’ Hormone Treatment Stumbles In Trials, Prompts Stock Freefall Spruce Biosciences’ Hormonal Disorder Candidate’s Future in Limbo: Analysts Downgrade Amid Tildacerfont’s Trial Setback – Spruce Biosciences (NASDAQ:SPRB) Read more
Biotechnology How Theriva Biologics Is Using An Adenovirus To Develop A Novel Treatment For Pancreatic Cancer, As Well As Other Cancers With An Unmet Need – Theriva Biologics (AMEX:TOVX) Read more